In our continuing search for compounds with antitumor-promoting activity, we screened eight xanthones isolated from Calophyllum elatum Bedd. (Guttiferae) by examining their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. Several compounds tested in this study showed inhibitory activity against EBV, without showing any cytotoxicity. Isogarciniaxanthone E (2) showed more potent activity than any of the other compounds tested. Furthermore, isogarciniaxanthone E (2) exhibited a marked inhibitory effect on mouse skin tumor promotion in an in vivo two-stage carcinogenesis test.
The genus Calophyllum is a member of the Guttiferae family, which includes many species of tropical trees. This genus is a rich source of xanthones and coumarins with a wide range of bioactivities, including cytotoxic, anti-HIV, antiviral, antitumor-promoting, antimalarial, and antibacterial effects [1] . Some species belonging to this genus are used in traditional medicine to treat peptic ulcers, tumors, infections, pain, inflammation, and other conditions [2a-d] . Our laboratory has reported that several xanthones, coumarins and flavonoids isolated from species of the Calophyllum genus exhibit potent cancer chemopreventative effects [3] [4] [5] [6] . This study sought to identify compounds with anticarcinogenic activity from Calophyllum elatum whose bioactivities have not been fully elucidated.
The acetone extract of the roots of C. elatum were subjected to silica gel column chromatography and preparative thin layer chromatography, yielding eight known compounds. The spectra of these compounds were compared with published spectral data and identified as 1,7-dihydroxyxanthone (1) [7] , isogarciniaxanthone E (2) [8] , globuxanthone (3) [9] , symphoxanthone (4) [10] , 12b-hydroxy-des-D-garcigerrin A (5) [11] , dulciol E (6) [12] , 7,9,12-trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one (7) [13] and rheediaxanthone A (8) [14] .
The eight identified xanthones (1) (2) (3) (4) (5) (6) (7) (8) were tested for their antitumor-promoting activity via a short-term in vitro assay using 12-Otetradecanoylphorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells (Table 1 ). Of the compounds tested, the 50% inhibitory concentration (IC 50 ) of isogarciniaxanthone E (2) was significantly lower than that of curucumin, which was used as a reference compound (232 vs. 341 mol ratio/32 pmol TPA). We previously reported that the 1,3-dihydroxyxanthone core and the prenyl group play an key role in anti-promoter activity [4, 15, 16] , supporting the observed bioactivity of isogarciniaxanthone E (2). The inhibition ratios of TPA-induced EBV-EA activation for globuxanthone (3), symphoxanthone (4) , and 12b-hydroxy-des-D-garcigerin A (5), which contain a 1,1-dimethylallyl group and two hydroxyl groups, were comparable to that of curucumin. In contrast, the dimethylpyran ring at C-6 and C-7 of the xanthone skeleton appeared to reduce anti-promoter activity.
The most active compound, isogarciniaxanthone E (2), was further evaluated in a mouse skin carcinogenesis assay. Mouse skin a Mol ratio/TPA (32 pmol = 20 ng/mL), 1000 mol ratio = 32 nmol, 500 mol ratio = 16 nmol, 100 mol ratio = 3.2 nmol, and 10 mol ratio = 0.32 nmol. Values are EBV-EA activation (%) ± standard deviation in the presence of the test compound relative to the positive control (100%). Values in parentheses represent the viability (%) of Raji cells measured by Trypan Blue staining. A minimum of 60% viability after 2 days after treatment is required for an accurate result. b IC 50 represents the mol ratio to TPA that inhibited 50% of the positive control (100%) activated with 32 pmol of TPA.
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c Reference compound. papillomas were generated by treatment with 7,12-dimethylbenz[a]anthracene (DMBA) and promoted by TPA. The carcinogenic kinetics of isogarciniaxanthone E (2) treatment group showed a rightward shift compared with the control group, suggesting that this compound may delay the onset of cancer ( Figure 2A ). In addition, isogarciniaxanthone E (2) decreased the average number of papillomas at 20 weeks by about 50% (isogarciniaxanthone E vs. control: 4.2 vs. 8.6 papillomas/mouse, Figure 2B ). Isogarciniaxanthone E (2) was previously reported to be cytotoxic toward Hela cells, showing an anti-cancer effect [17] . From these in vivo and in vitro results, isogarciniaxanthone E (2) may exhibit both an anti-cancer effect and a novel anti-carcinogenic bioactivity. This compound appears to be beneficial for cancer chemoprevention.
We have reported several xanthones, coumarins and flavonoids isolated from species belonging to the Calophyllum genus that show potent cancer chemopreventive effects [3] [4] [5] [6] . These results suggest that xanthones such as isogarciniaxanthone E (2) may hold promise for the development of cancer chemopreventive agents.
Experimental
Plant material: Calophyllum elatum Bedd. roots were collected in India. The plant was identified by Dr. Sivabalan Shanmugam of Annamalai University, India, and a voucher specimen has been deposited in Meijo University under number MUY0130.
Extraction and isolation:
Dried roots (980 g) of C. elatum were extracted at room temperature with acetone (3  4L). After evaporation of the solvent under reduced pressure, the acetone extract (17.8 g) was fractionated by silica gel column chromatography (100-200 mesh, 5.0 × 90 cm, 200 g) using successive elution with n-hexane-acetone (10:1, 500 mL; 4:1, 1000 mL; 3:1, 500 mL; 2:1, 500 mL; 1:1, 500 mL; approx. flow rate: 15 mL/min), acetone (500 mL), and MeOH (500 mL) to give 14 fractions. Preparative normal phase thin layer chromatography using n-hexane-EtOAc (5:2) was performed to purify Fraction 6-1 (74 mg), giving isogarciniaxanthone E (2, 10.2 mg) and globuxanthone (3, 8.4 mg). Fraction 6-2 (57 mg) was purified by preparative normal phase thin layer chromatography using CHCl 3 -MeOH (98:2) to afford symphoxanthone (4, 3.2 mg). Fraction 10, eluted with n-hexane-acetone (2:1), was separated by silica gel flash column chromatography (150-320 mesh, 20 g, 2.0 × 45 cm) by elution with n-hexane-acetone [(2:1), 600 mL] to provide dulciol E (6, 18.0 mg) and 7,9,12-trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one (7, 2.7 mg). The isolated compounds were identified by comparing their spectral data with data from the literature [7] [8] [9] [10] [11] [12] [13] [14] . The purity of these compounds was estimated to be at least 98% based on their NMR spectra. Figure 1 shows the structures of the isolated compounds.
In vitro EBV-EA activation experiments:
The inhibition of EBV-EA activation was investigated using a previously reported assay [15] , which we briefly describe below. Raji cells were grown to a density of 10 6 cells/mL, collected by centrifugation, and resuspended in RPMI 1640 medium (Nacalai Tesque, Kyoto, Japan) with 10% FCS containing 4 mM n-butyric acid as an inducer, 32 pmol of TPA (20 ng/mL in DMSO), and 32, 16, 3.2, or 0.32 nmol of the test compound (dissolved in DMSO). Cell counts and viability were measured with a hemocytometer (trypan blue staining method) after incubation for 48 h at 37 o C. Untreated cultures were used as controls. To estimate EBV-EA inhibitory activity, the count of positive cells treated with the test compound was divided by the count of positive control cells and expressed as a percentage. At least 500 cells were counted by a researcher blinded to the treatment status of the cells. Cancer chemopreventive xanthones from Calophyllum elatum Natural Product Communications Vol. 13 (4) 2018 449
In vivo two-stage carcinogenesis test on mouse skin papillomas promoted by TPA: Six-week-old female ICR mice were allocated in four experimental groups (15 animals each). The back skin of each mouse was shaved with surgical clippers, and DMBA (390 nmol in 0.1 mL acetone) was topically applied to the skin. One week after this treatment, papilloma formation was promoted twice a week by the topical application of TPA (1.7 nmol in 0.1 mL acetone) [18] .
